ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.41M	-
Other	Edwards Larry Todd	150.2K	$3.94M	-
Other	Matsuda Masaru	127.6K	$3.34M	-
Other	Burnett Patrick	120.2K	$3.15M	-
CFO	Vairavan Latha	86.0K	$2.25M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 3, 2025	Vairavan Latha	SVP Chief Financial Officer	Sell	88	$24.72	$2,175.23	-0.1%	+3.3%	-
Nov 3, 2025	Watanabe Todd65	See Remarks	Sell	11,547	$24.72	$285,399.17	-0.7%	+3.3%	-
Nov 3, 2025	Matsuda Masaru51	See Remarks	Sell	7,208	$24.72	$178,155.76	-2.3%	+3.3%	-
Nov 3, 2025	Welgus Howard G.61	Director	Sell	10,000	$25.27	$252,669.00	-10.0%	+3.3%	-
Oct 28, 2025	Watanabe Todd65	See Remarks	Sell	40,000	$25.03	$1,001,032.00	-4.7%	+5.5%	-
Oct 2, 2025	Edwards Larry Todd	See Remarks	Sell	4,504	$20.04	$90,263.31	-1.2%	+36.7%	-
Oct 2, 2025	Watanabe Todd65	See Remarks	Sell	45,000	$19.66	$884,648.68	-1.7%	+36.7%	-
Oct 1, 2025	Welgus Howard G.61	Director	Sale+OE	10,000	$18.92	$189,227.00	-4.8%	+42.1%	-
Sep 9, 2025	Watanabe Todd65	See Remarks	Sell	10,129	$17.54	$177,628.42	-0.6%	+73.1%	-
Sep 4, 2025	Matsuda Masaru51	See Remarks	Sell	36,130	$16.16	$583,716.28	-18.3%	+84.8%	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC